Researchers from Kindai University and collaborating institutions have achieved a significant milestone in cell biology by creating artificial cell nuclei within living mouse eggs. The study, published in the journal Genes to Cells [1], demonstrates for the first time that functional nuclei can be constructed by injecting purified DNA solution into oocytes, mimicking the fertilisation […]
In a significant advancement for neuroscience, researchers have successfully mapped nearly 140,000 neurons in the brain of a common fruit fly, creating the largest and most complete connectome of an adult animal to date. This groundbreaking work, supported by the U.S. National Institutes of Health (NIH), provides a detailed wiring diagram of the fruit fly […]
In a move towards greater environmental responsibility in the life sciences sector, Greiner Bio-One has announced that its serological pipettes have been awarded the ACT (Accountability, Consistency and Transparency) ecolabel. This certification, granted by the non-profit organisation My Green Lab, represents a significant step in providing scientists and procurement specialists with verified information about the […]
TThe acquisition of Alderley Analytical by Synexa Life Sciences marks a significant development in the bioanalytical services sector. This strategic move, announced on 7 October 2024, aims to broaden Synexa’s capabilities in biomarker and bioanalytical assays, particularly in the areas of mass spectrometry and ligand binding assays.
Cancer Research UK has announced funding of up to £600,000 for a groundbreaking project aimed at developing the world’s first ovarian cancer prevention vaccine. The initiative, led by Professor Ahmed Ahmed at the University of Oxford, seeks to leverage recent advancements in immunology and cancer biology to create a vaccine that could potentially prevent ovarian […]
In a move that signals a shift towards commercial growth and technological advancement, Cambridge-based biotechnology company Nuclera has announced significant changes to its leadership structure. The firm, known for its eProtein Discovery system – a benchtop platform designed to accelerate protein expression and purification workflows – has promoted three key executives to senior roles.
Paris-based AzurBio Pharma has officially launched, positioning itself as a strategic partner for biopharmaceutical companies seeking to bring innovative treatments to the European market. The company, founded by industry veteran Corinne Schmitz, aims to streamline the often complex process of European market entry, with a particular focus on rare and serious diseases with unmet medical […]
The merger of Calyx and Invicro has culminated in the launch of a new corporate entity, Perceptive, marking a significant development in the biopharmaceutical services sector. This rebranding reflects the organisation’s enhanced capabilities in providing comprehensive support throughout the drug development lifecycle.
Norgine, a prominent European specialty pharmaceutical and consumer healthcare company, has announced a significant leadership change with the appointment of Janneke van der Kamp as its new Chief Executive Officer (CEO), effective 1 January 2025. This move comes as part of the company’s strategy to enhance its mission of delivering transformative medicines to patients and […]
A team of interdisciplinary researchers from the Fraunhofer-Gesellschaft has unveiled a new method for producing fine chemicals, including those used in pharmaceuticals, potentially transforming the traditionally complex and labour-intensive manufacturing process. The novel approach, modelled on a cascade system, allows multiple successive stages of synthesis to proceed without interruption, offering significant improvements in efficiency and […]
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
